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Strategies for grouping per- and polyﬂuoroalkyl
substances (PFAS) to protect human and
environmental health
Ian T. Cousins, *a Jamie C. DeWitt, b Juliane Glüge, c Gretta Goldenman,d
Dorte Herzke, ef Rainer Lohmann, g Mark Miller,h Carla A. Ng, i
Martin Scheringer, c Lena Vierkej and Zhanyun Wang k
Grouping strategies are needed for per- and polyﬂuoroalkyl substances (PFAS), in part, because it would be
time and resource intensive to test and evaluate the more than 4700 PFAS on the global market on
a chemical-by-chemical basis. In this paper we review various grouping strategies that could be used to
inform actions on these chemicals and outline the motivations, advantages and disadvantages for each.
Grouping strategies are subdivided into (1) those based on the intrinsic properties of the PFAS (e.g.
persistence, bioaccumulation potential, toxicity, mobility, molecular size) and (2) those that inform risk
assessment through estimation of cumulative exposure and/or eﬀects. The most precautionary grouping
approach of those reviewed within this article suggests phasing out PFAS based on their high persistence
alone (the so-called “P-suﬃcient” approach). The least precautionary grouping approach reviewed
advocates only grouping PFAS for risk assessment that have the same toxicological eﬀects, modes and
mechanisms of action, and elimination kinetics, which would need to be well documented across
diﬀerent PFAS. It is recognised that, given jurisdictional diﬀerences in chemical assessment philosophies
and methodologies, no one strategy will be generally acceptable. The guiding question we apply to the
reviewed grouping strategies is: grouping for what purpose? The motivation behind the grouping (e.g.
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determining use in products vs. setting guideline levels for contaminated environments) may lead to
diﬀerent grouping decisions. This assessment provides the necessary context for grouping strategies
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such that they can be adopted as they are, or built on further, to protect human and environmental
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health from potential PFAS-related eﬀects.

Environmental signicance
PFAS comprise more than 4700 individual substances that are used in many, highly diverse applications in society. All PFAS are very persistent (if PFAS with
persistent transformation products are considered as persistent substances, as is the case under REACH) and several PFAS are also known to be bioaccumulative
and toxic. However, for most PFAS there are insuﬃcient data to facilitate chemical assessments. Generating these missing data on a chemical-by-chemical basis
is too resource intensive and it is therefore essential to identify groups of similar PFAS that can be assessed together. Here we discuss various grouping
approaches and their advantages and limitations. The structural diversity of PFAS poses a challenge to grouping. However, some kind of grouping approach, or
a combination of several diﬀerent approaches, will be needed for the future assessment and management of PFAS.
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Introduction
Buck et al.1 provided the rst class denition of per- and polyuoroalkyl substances (PFAS) as “the highly uorinated
aliphatic substances that contain 1 or more C atoms on which
all the H substituents. have been replaced by F atoms, in such
a manner that they contain the peruoroalkyl moiety CnF2n+1–”
(where n is equal to or greater than 1, i.e. the structure must
contain at least one CF3– group). A more recent and broader
denition by the Organisation for Economic Co-operation and
Development (OECD)/United Nations Environment Programme
(UNEP) Global PFC Group2 dened PFAS as chemicals with at
least one peruorocarbon moiety (–CnF2n–). PFAS therefore
comprise a diverse group of chemistries with the common
feature of the fully or “per”-uorinated carbon chain.
Structurally diverse PFAS are used in a wide variety of
commercial products and industrial applications. In the 2018
OECD PFAS list2 over 4700 CAS numbers were identied for
PFAS on the global market. For the majority of PFAS, little or no
data on uses, properties and eﬀects are available to determine
how these chemicals may impact the health of living organisms.3–6 Our current understanding of biological impact is
based primarily on studies of four PFAS, peruorooctane
sulfonic acid (PFOS), peruorooctanoic acid (PFOA), peruorohexane sulfonic acid (PFHxS), and peruorononanoic
acid (PFNA).7 Epidemiological studies of human populations
suggest that PFAS may act as endocrine and metabolic disruptors, increase cholesterol levels, adversely impact the
immune system, and cause cancer.7 These data are supported
by studies in laboratory animals showing changes in liver,
thyroid, immune and pancreatic function.7
But researching individual chemicals is both expensive and
time consuming. It can take many years to gather the evidence
needed under regulatory regimes to restrict harmful chemicals.
It is becoming increasingly apparent that to eﬀectively protect
the public and environment from the wide range of possible
PFAS-related environmental and human health eﬀects, strategies should be sought to group PFAS for action, e.g. for guiding
regulatory and voluntary phase-out actions, etc., rather than to
address them chemical-by-chemical. For example, in the recent
Zurich Statement,8 the authors recommended “that actions
need to address groups of PFAS rather than individual chemicals and that such a grouping approach needs to be scientically sound.” It was further recognized “that a grouping
approach requires a better mechanistic understanding of the
physicochemical and toxicological properties of PFAS as well as
additional data that can be used to support grouping
approaches for PFAS.”
Between 2000 and 2002,9 aer about 50 years of continuous
manufacture, 3M phased out all PFAS products derived from
peruorooctane sulfonyl uoride (POSF; C-8) and its C-6 and C10 homologues, which represented the rst large-scale
grouping of hundreds of PFAS for voluntary phase-out. Shortly
thereaer, in 2006, eight major PFAS manufacturers committed
to eliminating the global use and emissions of PFOA, its longerchain homologues, and their precursors by 2015 through the
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PFOA Stewardship program10 agreement with the US Environmental Protection Agency (US EPA).
In conjunction with these phase-outs, the uorochemical
industry introduced another grouping approach, namely the
concept of “long-chain” and “short-chain” peruoroalkyl acids
(PFAAs),11 dening long-chain PFAAs as only peruoroalkyl
carboxylic acids (PFCAs) with $7 peruorinated carbons and
peruoroalkane sulfonic acids (PFSAs) with $6 peruorinated
carbons. While emerging evidence showed long-chain PFAAs
are bioaccumulative and toxic, the PFAS manufacturing
industry held that short-chain PFAAs were not, and thus one of
the strategies of the PFAS manufacturing industry was to
replace long-chain PFAAs with their short-chain homologues.12
Another substitution strategy is to replace long-chain PFAAs
with substances containing peruoroalkyl ether moieties (e.g.
per- and polyuoroalkyl ether carboxylic and sulfonic acids
(PFECAs and PFESAs)).12
It is now apparent that this industry substitution strategy for
long-chain PFAAs requires reconsideration given (1) the widespread environmental contamination (including drinking water
sources) by short-chain PFAAs13 and peruoroalkyl ether acids14
due to their high environmental mobility and (2) the listing of
both hexauoropropylene oxide dimer acid (HFPO-DA, sometimes referred to as GenX), a PFOA-replacement introduced by
DuPont in 2009 that contains peruoroalkyl ether moieties, and
peruorobutane sulfonic acid (PFBS), a short-chain PFAA that is
the ultimate degradation product of 3M's replacement chemistry (introduced in 2003), as Substances of Very High Concern
(SVHCs) under the EU REACH Regulation.15
Given the number of substitutions of long-chain PFAAs with
other PFAS that are now also considered to be problematic,
there is a need for more eﬀective grouping strategies for the
regulation of PFAS than the current approach of regulating only
long-chain PFAAs and related substances. In the Madrid Statement,16 more than 200 scientists and regulators suggested that
PFAS should be managed as a class, and that production and
use should be limited. This grouping of all PFAS for phase-out is
based on concerns regarding the high persistence of PFAS, the
lack of knowledge on chemical structures, properties, uses, and
toxicological proles of most PFAS currently in use, and the
need for informed substitutions of problematic PFAS chemistries.16 A counterpoint to regulating PFAS as a class, authored by
the FluoroCouncil17 in response to the Madrid Statement, stated
(among other things) that PFAS are a structurally diverse group
exhibiting “important diﬀerences between the health and
environmental impacts”, and that “uorotechnology is essential technology for many aspects of modern life”.
The Montreal Protocol's concept of essential use has been
put forward as an approach for reducing exposure to PFAS, by
phasing out all non-essential uses of PFAS.18 While such
a phase-out of PFAS is likely not feasible in the short term, it is
not an insurmountable challenge in the longer term. Indeed,
within the European Union (EU), there are already discussions
underway for a restriction proposal for all non-essential uses of
PFAS,19,20 although it is not yet known how “essential use” will
be dened. Innovation, in conjunction with regulation and
economic incentives for the development of new technologies,

Environ. Sci.: Processes Impacts, 2020, 22, 1444–1460 | 1445

View Article Online

Open Access Article. Published on 04 June 2020. Downloaded on 10/14/2020 5:56:55 PM.
This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

Environmental Science: Processes & Impacts
should in time provide functional alternatives to even current
essential uses of PFAS.18 In cases where the uses of PFAS are
seen as “necessary for health, safety or is critical for the functioning of society”16 but no functional alternatives with
favourable hazard properties are currently available, certain
uses of PFAS will probably continue, at least in the short term.18
However, the use of the grouping strategies presented here
could provide opportunities for market adjustment, and spark
more voluntary eﬀorts to reduce non-essential uses.18
The aims of this paper are to discuss (1) current and
potential grouping strategies that inform PFAS assessment for
various control actions, with advantages and disadvantages for
each, (2) highlight motivations for action that could guide use of
specic grouping approaches and (3) outline the way forward
and remaining challenges in advancing these grouping
approaches.

Motivations for grouping
The method used to group PFAS depends on the type of action
intended. Grouping PFAS may have benets, for example: (1) to
more eﬃciently protect human and environmental health, (2) to
avoid animal testing through read across,21 (3) for product
labelling and consumer education (e.g. for interpretation of
a label such as “PFAS free”), or (4) to manage clean-up of
contaminated sites.
Most existing grouping approaches have been developed to
protect human and environmental health from potential
adverse eﬀects resulting from exposure to the multiple PFAS in
commerce. Moreover, further motivations for grouping of PFAS
are based on their environmental and biological persistence,
the high number of individual PFAS, and the lessons learned
from recent industrial substitution strategies.
Proactive strategies concerning new or continued use of
PFAS may benet from more precautionary grouping
approaches because these decisions will directly impact future
exposures and because their implementation – at least avoidance of non-essential uses – will always be less costly than
retrospective risk assessment and remediation. On the other
hand, decisions for how to group already emitted PFAS for the
establishment of drinking water guidelines or environmental
cleanup levels will have profound impacts on enforcement
including costs and resource needs. It may therefore be necessary, in resource-constrained settings, to more strictly prioritize
cleanup levels on the basis of established toxicological risk.

Grouping approaches
Here existing grouping approaches to protecting human and
environmental health are subdivided into (1) those based on the
intrinsic properties of the PFAS and (2) those that inform risk
assessment through estimation of cumulative exposure and/or
eﬀects (see Fig. 1). National or international chemical assessments rely on intrinsic properties of the chemical, including its
persistence (P), bioaccumulation (B) and toxicity (T). This “PBT
approach” can be found for example in the EU REACH Regulation.22 Under REACH, substances can also be identied as
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“Substances of Very High Concern” (SVHC) if they are very
persistent (vP) and very bioaccumulative (vB) meaning that if
these criteria can be met, toxicity does not require
consideration.
The approaches that inform risk assessment, on the other
hand, consider anticipated exposure when determining
whether or not an adverse eﬀect to human health or the environment may occur. For example, the point of departure for
establishing acceptable risk could be the no observed adverse
eﬀect level (NOAEL) for a critical toxicological endpoint. The
NOAEL can then be compared to either the external dose or
exposure (e.g. concentration in exposure medium) or internal
dose or exposure (e.g. serum or tissue concentration) to determine the risks.
Risk assessment has typically been performed on a chemicalby-chemical basis, but there is some current focus on developing methods for combined risk assessment through estimation of cumulative exposure (e.g. total organouorine (TOF) or
extractable or adsorbable organouorine (EOF/AOF)) and/or
eﬀects (e.g. additive).23 Such combined risk assessment is
challenging for multiple PFAS, given that suﬃcient toxicity data
are only available for relatively few (<20) substances.7
Measurement of exposure can be achieved for more substances,
but may be constrained by the lack of knowledge of what/how to
measure and also lack of analytical standards.
Each individual approach is discussed in more detail in the
following sections. It is important to note that the individual
grouping approaches were developed for diﬀerent purposes,
have diﬀerent data needs, and therefore cannot always be
directly compared to each other. The selection of the grouping
approach needs to account for the specic protection goal, data
requirements and enforcement techniques.

Grouping approaches based on
intrinsic properties
Grouping according to the “P-suﬃcient” approach
The continuous release of persistent chemicals will lead to
widespread, long-lasting, and increasing contamination, which
will inevitably result in increasing probabilities of known and
unknown adverse eﬀects on human health and the environment.24 The peruoroalkyl (CnF2n+1–) and peruoroether
(CnF2n+1–O–CmF2m–) moieties are highly persistent under environmental conditions.4 Although some polyuoroalkyl
substances (so called “precursors”) may degrade in the environment and biota, they all ultimately (partially) transform into
highly stable end products, which are usually the persistent
PFAAs.3 This view is consistent with the REACH Regulation that
all chemicals with persistent transformation products should
be classied as persistent.22 Based on this denition, all PFAS
are therefore considered to be very persistent in environmental
media, and under the proposed “P-suﬃcient” approach all PFAS
would be managed as a single group.
An advantage of this approach is that it is easily implementable to all PFAS for non-experts, i.e. non-experts will not
need to ask if a (new) PFAS belongs to the group or not. A
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Fig. 1

Grouping approaches for PFAS.

disadvantage of the “P-suﬃcient approach” is that no legal
precedent has been made in any jurisdiction, although the idea
of regulating highly persistent chemicals and microplastics is
being explored within the EU.25,26

Grouping according to the PBT/vPvB approach
As mentioned in the introduction, PFAAs have been grouped
into long-chain and short-chain PFAAs, where long-chain PFAAs

This journal is © The Royal Society of Chemistry 2020

are considered bioaccumulative in animals and short-chain
PFAAs are not.11 A major disadvantage in the current grouping
of long- versus short-chain PFAAs to determine if PFAS are
bioaccumulative is that the denitions of long- and short-chain
PFAAs only apply to PFCAs and PFSAs;11 however, it has been
suggested that there are other PFAS that are bioaccumulative.
To more accurately dene those PFAS that are bioaccumulative,
new grouping approaches would be required; a few suggestions
are provided below.
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There are already a number of PFAS that are suggested to be
bioaccumulative according to observations from bioaccumulation experiments. For example, certain peruoroalkyl
phosphonic and phosphinic acids (PFPAs and PFPIAs) can only
be slowly eliminated from rainbow trout27 and rats,28 similarly
to long-chain PFCAs and PFSAs.29 There is also evidence that
peruorotripropyl amine is bioaccumulative based on the long
elimination half-lives observed in the liver and spleen of rats.30
Peruorooctane is also potentially bioaccumulative based on
bioconcentration factor (BCF) measurements in European carp
(BCF up to 3200 L kg1) and rice sh (BCF up to 13 600 L kg1).31
Finally, chlorinated PFESAs, predominately the so-called 6:2 ClPFASA (oen called F-53B, CAS no. 73606-19-6), and a novel
PFECA, peruoro-2-[(propoxy)propoxy]-1-propanoate have been
shown to bioaccumulate in biota and human serum.32–35
Indications of bioaccumulation that need further evaluation
are the observations of a number of emerging and novel PFAS in
top predators including humans. For example, peruoro-4ethylcyclohexane sulfonate has been detected in top predator
sh in the Great Lakes36 and in crucian carp in China.37 PFPIAs,
predominately 6:8 PFPIA (cormorants and pike) and 6:6 PFPIA
(dolphins), have been observed in biota in North American
inland and coastal waters.38 PFPAs, predominately

Critical Review
peruorohexyl phosphonate (PFHxPA), have been detected in
a Norwegian human cohort.39
Fig. 2 illustrates the structures of some PFAS suggested to be
bioaccumulative. A common feature of the PFAS in Fig. 2 is that
they contain at least six peruorinated carbons. The head group
of PFAAs is also known to inuence their bioaccumulation
potential; for example, it is well known that PFSAs are more
bioaccumulative than PFCAs with the same peruorinated
carbon chain length.11
Both computational and empirical methods have been
explored to estimate protein binding aﬃnity. In vitro methods
include, among others, equilibrium dialysis40 and uorescence
displacement.41,42 In a recent paper, Yang et al.43 used a nontarget screening approach to identify novel PFAS present in
aqueous lm forming foams (AFFF) that bind to human liver
fatty acid binding protein. Computational methods are based
on structure–property relationships and could potentially be
used to estimate the bioaccumulation potential of novel and
emerging PFAS. For example, the protein aﬃnity of certain
legacy and novel PFAS was recently estimated using molecular
dynamic approaches,44 and protein aﬃnity is a key determinant
of bioaccumulation potential. Such structure–property relationships may also aid in estimating the elimination half-lives

Fig. 2 Chemical structures of various potentially bioaccumulative PFAS (other than the already well-known long-chain PFAAs). Note that this
ﬁgure only provides a few examples of potentially bioaccumulative PFAS from the wider universe of PFAS.
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of PFAS, which is another important factor in determining
bioaccumulation potential. Predictive approaches for bioaccumulation potential will be especially important for
informing grouping, as they are proactive and resource-eﬃcient
in comparison to biomonitoring and laboratory testing (in vitro
or in vivo testing).
Short-chain PFAAs have not been reported to bioaccumulate
in animals,11 but are known to bioaccumulate in above-ground
plant tissues (shoots, leaves and fruit).45–48 An inverse relationship has been observed between peruoroalkyl chain length
and BCFs of PFAAs in above-ground plant tissues for edible
crops grown in sludge-amended soils.47 In regions where the
soil is highly contaminated with short-chain PFAAs, human
exposure from consumption of crops can become an important
pathway.49
A fundamental limitation of grouping according to bioaccumulation potential (B) is that for highly persistent chemicals, B may become less relevant if a high exposure is achieved
via other pathways than uptake and accumulation within the
body. It has been argued50 that B is not a suﬃcient criterion for
protecting against poorly reversible eﬀects because the residence time of highly persistent chemicals in the environment is
oen much greater than their residence time in humans and
biota, which means that levels in organisms will be poorly
reversible regardless of the magnitude of B. The limitations of
the PBT and vPvB assessment criteria were the motivation for
the development of other complementary chemical management approaches such as the “P-suﬃcient” and the “PMT/
vPvM” approaches. On the other hand, the PBT/vPvB approach
is a well-established regulatory framework.

Grouping according to the PMT/vPvM approach
The German Environment Agency (UBA) has recently proposed
a PMT/vPvM approach for identifying substances that may pose
a threat to sources of drinking water.51 The approach presents
and discusses updated guidelines for using the REACH registration process to identify persistent, mobile, and toxic (PMT)
substances as well as very persistent and very mobile (vPvM)
substances. The motivation for this approach is to pinpoint
substances that might require control to protect waters used as
sources for drinking water or food production. The PMT
approach classies substances considered persistent in the
environment (P), mobile in the aquatic environment (M) and
toxic (T). For substances identied as very persistent (vP) and
very mobile (vM), it is not necessary to consider toxicity data.51
Under this concept, the short-chain PFAAs and many other
replacements of long-chain PFAAs such as HFPO-DA, which are
both vP and vM, would be identied.
A consequence of introducing the PMT/vPvM approach is
that, in combination with the existing PBT/vPvB approach
under REACH, a wide range of substances that are vP would be
covered. Hydrophobic substances with a high octanol–water
partition coeﬃcient (KOW) (e.g. KOW cutoﬀ of log KOW > 5 under
the Stockholm Convention on Persistent Organic Pollutants)
would be covered by the vPvB approach, and hydrophilic
substances with low KOW (a cutoﬀ of log KOW < 4 under the
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proposed PMT/vPvM approach) would be covered by the vPvM
approach. Therefore, the authors of the “P-suﬃcient” approach
argue that partitioning properties such as KOW, KOC (organiccarbon-water partition coeﬃcient) and the BCF are irrelevant
and that PFAS should be managed according to their high
persistence alone.24 Similar to the “P-suﬃcient approach” the
PMT/vPvM approach is still a proposal and not currently
broadly implemented under REACH.
Grouping some uoropolymers as “polymers of low concern”
PFAS are broadly subdivided into low molecular weight
substances and uorinated polymers.1 There are three
subclasses of uorinated polymers that meet the PFAS structural denition and these are termed: uoropolymers, peruoropolyethers and side-chain uorinated polymers.1
According to Buck et al.,1 uoropolymers are a distinct subset of
uorinated polymers made by (co)polymerization of olenic
monomers, at least one of which contains uorine bound to one
or both of the olenic carbon atoms, to form a carbon-only
polymer backbone with uorine atoms directly attached to it,
e.g., polytetrauoroethylene (PTFE).
It was recently suggested that a subset of uoropolymers
should be considered distinct from other uorinated polymers
based on international criteria for “polymers of low concern”
(PLC) due to (among other things) their high molecular weight,
narrow molecular weight distribution, negligible oligomer
content and organic and inorganic leachables.52 Classication
as PLC may exempt the manufacturers of certain uoropolymers from certain regulatory notication requirements. Integration of the PLC criteria into a risk management framework
may diﬀer from country to country according to individual
regulatory mandate.52 Although a recent framework for polymer
risk assessment recommended consideration of impacts
throughout the lifecycle of a polymeric product,53 Henry et al.52
limited their assessment of uoropolymers to the use phase.
However, there are serious concerns regarding the environmental impacts of uoropolymers during manufacture
(“beginning of life”) and waste management (“end of life”) that
need to be addressed. Specically: (i) some uoropolymers (e.g.
PTFE ne powder) are still manufactured in Asia using processing aids containing hazardous long-chain PFAAs (e.g.
PFOA), which are widely distributed in the Asian environment54
and can undergo long-range global transport,55,56 (ii) there are
concerns among scientists and regulators regarding the
substitute processing aids used (e.g. HFPO-DA is now an SVHC
under the EU REACH regulation),15 (iii) a wide range of potentially hazardous byproducts have been observed in the environment near uoropolymer manufacturing sites,14,57,58 (iv)
environmental emissions of these persistent polymers during
use and at end of life are problematic given the current concern
regarding persistent microplastics in the environment (even if
uoropolymer plastic waste is of relatively low volume),59 and (v)
the best available technology for treatment of solid wastes is
currently incineration, from which emissions of harmful
chemicals including certain PFAS could occur if incineration is
not operated according to international guidelines.60 The PLC
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criteria should be applied on a product-by-product basis
because individual uoropolymer products (e.g. due to diﬀerent
impurity levels) may not meet the PLC criteria.

Grouping approaches that inform risk
assessment
Arrowhead approach: grouping PFAAs together with their
precursors
The so-called “arrowhead approach” is dened as when
a representative PFAS (usually a PFAA) is managed together with
its salts and precursors. The approach represents the dominant
current approach to grouping PFAS for risk assessment and risk
management globally. Industry have used the approach in
voluntary phase-out actions (e.g. 3M 9) of PFAS chemistries and
it is applied globally in PFAS regulations. For example, precursors to long-chain PFAAs have been grouped together with
specic PFAAs in risk management (e.g. under REACH,61,62 in

Table 1
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the Stockholm Convention,63,64 see Table 1, or are currently
under discussion, see Table 2) given that these precursor
substances will transform to an “arrowhead substance of
concern” (i.e. the long-chain PFAAs that have PBT properties) in
the environment, in biota, or in humans. There is no indication
of how many substances, past or present, are covered by denitions such as, “PFOA, its salts and PFOA-related compounds”.
There are thousands of substances that can theoretically be
broken down into PFOA, but it is not clear which of them are or
have been used.
Although the arrowhead approach is an eﬃcient way of
assessing and regulating large groups of chemicals simultaneously there are some limitations. One limitation is that the
approach may overlook the risks from the parent PFAS themselves, or intermediate degradation products that are formed
along the pathway to the presumed arrowhead degradation
products. For example, a recent study demonstrated that 6:2
uorotelomer alcohol (6:2 FTOH) is signicantly more toxic to
rodents than peruorohexanoic acid (PFHxA).65 The authors

PFAAs and their precursors that have been grouped together

Substances

What is included

Context

PFOA, its salts and
PFOA-related compounds63

Peruorooctanoic acid (PFOA), its salts and PFOA-related
compounds means the following: (i) peruorooctanoic acid
(PFOA; CAS no. 335-67-1), including any of its branched
isomers; (ii) its salts; (iii) PFOA-related compounds which, for
the purposes of the convention, are any substances that
degrade to PFOA, including any substances (including salts
and polymers) having a linear or branched peruoroheptyl
group with the moiety (C7F15)C as one of the structural
elements

Stockholm Convention on
Persistent Organic
Pollutants (POPs)

The following compounds are not included as PFOA-related
compounds: (i) C8F17–X, where X ¼ F, Cl, Br; (ii)
uoropolymers that are covered by CF3[CF2]n–R0 , where R0 ¼
any group, n > 16; (iii) peruoroalkyl carboxylic and
phosphonic acids (including their salts, esters, halides and
anhydrides) with $8 peruorinated carbons; (iv)
peruoroalkane sulfonic acids (including their salts, esters,
halides and anhydrides) with $9 peruorinated carbons; (v)
peruorooctane sulfonic acid (PFOS), its salts and
peruorooctane sulfonyl uoride (PFOSF), as listed in Annex B
to the Convention
PFOA, its salts and
PFOA related compounds62

Any related substance (including its salts and polymers)
having a linear or branched peruoroheptyl group with the
formula C7F15– directly attached to another carbon atom, as
one of the structural elements. Any related substance
(including its salts and polymers) having a linear or branched
peruorooctyl group with the formula C8F17– as one of the
structural elements. The following substances are excluded
from this designation: C8F17–X, where X ¼ F, Cl, Br – C8F17–
C(]O)OH, C8F17–C(]O)O–X0 or C8F17–CF2–X0 (where X0 ¼ any
group, including salts)

EU REACH restriction
(REACH Annex XVII entry
68)

PFOA, its salts and
precursors
as well as long-chain (C9–
C20) PFCAs,
their salts and precursors66

PFOA, its salts and precursors as well as long-chain (C9–C20)
PFCAs, their salts and precursors

Order Adding Toxic
Substances to Schedule 1 of
the Canadian
Environmental Protection
Act, 1999
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Grouping of PFAAs and their precursors currently under discussion

Substances

Context

Undecauorohexanoic acid (PFHxA), its salts and related substances67

EU REACH restriction proposal

Peruorononan-1-oic acid (PFNA); nonadecauorodecanoic acid (PFDA);
henicosauoroundecanoic acid (PFUnDA); tricosauorododecanoic acid
(PFDoDA); pentacosauorotridecanoic acid (PFTrDA); heptacosauorotetradecanoic acid (PFTDA) including their salts and precursors68

EU REACH restriction proposal

PFHxS, its salts and PFHxS-related compounds as well as polymers and
mixtures64

Proposed for listing under the Stockholm
Convention on Persistent Organic Pollutants

PFHxS, its salts and related substances69

EU REACH restriction proposal

concluded that the use of toxicological studies conducted with
PFHxA to assess 6:2 FTOH exposure may signicantly underestimate human health risk.
Challenges with the above groups are the lack of an
exhaustive list of present precursors and analytical methods for
individually measuring all relevant precursors to a specic PFAA
in a certain medium. Although it was primarily developed as
a research tool,70 the total oxidizable precursor (TOP) assay is
a potential solution to quantifying PFAAs and their precursors.
The TOP assay has been primarily applied to quantify precursors that can be oxidized to PFAAs in water samples,70 although
it has further been developed and applied to a wider range of
sample types, e.g. soils,71 paper and textiles.72
Application of the TOP assay usually involves quantifying
PFAAs in samples using targeted analysis before and aer treatment with powerful oxidizing agents.70 The diﬀerence between
the levels of PFAAs before and aer treatment is considered to be
an indicator of the total concentration of the oxidizable PFAA
precursors, because PFCAs and PFSAs that were present in the
original sample remain mostly intact under the conditions of the
assay. Currently it is not possible to apply the TOP assay to
enforce the PFOA restriction under REACH in Table 1 because,
for example, PFOA might be formed during TOP assay oxidation
from a precursor which is not within the restriction scope.
Levels of PFAAs in drinking water samples could be compared
to drinking water guidelines aer the samples have been treated
with the TOP assay. An advantage of this approach is that
precursors would be included that could be transformed in the
water or metabolized to PFAAs inside the body aer intake. On
the other hand, the TOP assay may not simulate environmental
transformation and metabolic processes accurately. The assay is
an aggressive oxidation process that generates shorter-chain
PFAAs than natural environmental oxidation processes, and
even degrades polyuoroalkyl ether acids with –O–CFH– moieties.73 Furthermore, it may overestimate the contribution of some
precursors to PFAA body burdens, and underestimate others and,
thus, inaccurately estimate the risks. For example, the TOP assay
transforms peruorooctane sulfonamide (FOSA) to PFOA,70
whereas FOSA is likely metabolized to PFOS in vivo in humans.74
An enzyme-based assay would be preferable to simulate biological transformations, but is not yet broadly available. Finally, the
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TOP assay has not to date been standardized so results from
diﬀerent laboratories may be inconsistent.75
Total uorine and extractable/adsorbable organouorine
approaches
Driven by the need for fast and inexpensive analytical methods
to determine the presence or absence of PFAS in a given sample
and by the lack of analytical standards for most known and
unknown PFAS, total uorine (TF) and extractable/adsorbable
organouorine measurements have been put forward.72,76–79
These methods could also be used in screening-level exposure
assessments, e.g. to determine if the level of total extractable/
adsorbable organouorine in a sample is below or above
a pre-dened limit, which would trigger further chemical
assessment and management measures including more indepth targeted analysis.
TF comprises the sum of all uorine as a surrogate for all
inorganic and organic uorinated substances in a sample.76 TF
can be measured through particle-induced gamma(g)-ray
emission (PIGE) spectroscopy, X-ray photoelectron spectroscopy
(XPS) and combustion ion chromatography (CIC). PIGE spectroscopy is an ion beam technique used for the analysis of
uorine in solid materials, and liquids aer solid-phase
extraction.72 XPS has also recently been used for uorine mass
balance experiments in consumer products.77 CIC involves
combusting samples or extracts, collecting uoride ions in
water and then separating them on an ion exchange column,
and has also been applied to consumer products.78
Today, TF is used in Denmark with an oﬃcial indicator value
of 0.1 mg cm2 for food packaging.80 The indicator value can
help industry and regulators assess whether organic uorinated
substances have been added to paper and cardboard. Furthermore, it can inform if PFAS levels are increasing over time. If the
indicator level is exceeded, this can justify further analyses
needed for risk assessment. The fast application of TF methods
and relatively simple evaluation of results (yes and no for
presence of uorine) is appealing. The relatively high detection
limits of TF methods and lack of specicity (cannot specify if TF
is PFAS) are drawbacks. Assuming a 10 mg sample size, detection limits for TF were recently reported as 0.8 and 38 mg g1 for
CIC and PIGE in paper samples, respectively, which is at least
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1000 times higher compared to modern PFAS analysis by liquid
chromatograph-tandem mass spectrometry (LC-MS/MS).78
Depending on the sample type, a certain fraction of the TF
can be extracted using organic solvents (extractable organic
uorine, EOF). Alternatively, the PFAS in aqueous samples can
be extracted using a sorbent, which is then analyzed for TF
(adsorbable organic uorine, AOF). The EOF/AOF fraction in
a sample can be assumed to contain primarily synthetic organouorine substances given the low abundance of naturally
occurring ones, rarely exceeding more than one uorine per
molecule.79 By comparing the concentration of EOF/AOF with
the total PFAS measured in a sample by targeted analysis, the
fractions of known and unknown organouorine substances
can be determined. If the unknown fraction of organouorine
substances is large in a given sample, then this can be probed
using non-targeted analytical methods.14,57,81 As shown in recent
literature, the explainable contributions of EOF to the TF in,
e.g., cosmetics,82 seawater,83 food packaging,78 contaminated
water83 and human blood84 may be 0.1–3%, 2%, 5.5%, 30% and
80%, respectively. Fig. 3 illustrates uorine-containing chemicals covered by available analytical methods.
For estimating the drinking water exposure to total PFAS, EOF/
AOF could be potentially used instead of targeted analysis for
groups of PFAS. For example, in the EU very likely a ‘PFAS total’
limit of 500 ng L1 will be provisionally set in a recast of the
Drinking Water Directive85 and EOF/AOF could potentially be
used to relatively rapidly determine if a sample is below this
500 ng L1 limit. An advantage of the EOF/AOF approach is that
all PFAS would be captured in a single measurement that is
relatively inexpensive compared to targeted LC-MS/MS methods
for individual PFAS. EOF/AOF measurement approaches may
further help to determine if unknown PFAS are released to the
environment from production sites and are present in drinking
water or a particular product (e.g. ski waxes or food contact
materials). They are therefore good screening approaches that can
be followed up with non- or suspect-targeted analytical methods
to identify substances in the unknown PFAS fraction.14,57,81 A
disadvantage, however, would be uncertainties in translating the
EOF/AOF measurements into risk-based guidelines. A “worst

Critical Review
case” assumption could be that the EOF/AOF concentration is
equal to the concentration of the most toxic PFAS known (e.g.
typically PFOS or PFOA, see Table 1). This approach may be
considered precautionary and protective, but on the other hand,
humans are exposed to a lot of unknown PFAS with unknown
risks, which may be more toxic than the currently known ones.
Another disadvantage of this approach in its application to PFAS
is that it will likely capture organouorine substances that are
currently not considered as PFAS (e.g. uorinated substances
used as pharmaceuticals and pesticides). Finally, a common
problem with TF, EOF/AOF and the TOP assay is that these
methods require further development before they can be
considered suﬃciently reliable for regulatory applications. Eﬀorts
are underway to assess, further develop and standardize methods
as well as to conduct inter-laboratory comparison studies.
Simple additive toxicity approach: application to drinking
water standards
Regulatory agencies worldwide have developed guidelines or
advisories for acceptable levels of PFAS in drinking water.
Because there are so many PFAS and only limited toxicological
and toxicokinetic data for most of them, it is challenging to
generate guidelines for individual PFAS, let alone robust
grouping strategies. Some regulatory agencies have grouped
multiple PFAS together and set one limit for the combined (sum
of) concentrations of these chemicals (Table 3). A simple
example is the combined drinking water health advisory of
70 ng L1 set by the US EPA for the sum of PFOA and PFOS.86
The assumptions made in this grouping are that the critical
toxicological endpoint is the same for the two substances (i.e.,
developmental toxicity) and that the margin of safety (MOS, i.e.
the ratio of NOAEL obtained from animal toxicology studies to
the predicted or estimated human exposure level or dose) is
similar. In Sweden, 11 diﬀerent PFAS87 are grouped with the
limit of 90 ng L1 for the sum of these 11 PFAS, above which
consumption of drinking water is not recommended.
The simple additive toxicity approach has the advantage that
it is easy to understand and environmental or health-based
guidelines can be evaluated with current analytical methods.
Furthermore, it is thought to be protective for humans and the
environment in that the additive toxicity is based on the most
toxic PFAS in the group. Scientic shortcomings of the simple
additive toxicity approach that sums multiple PFAS are that (1)
it assumes an external dose-additive model88,89 whereas elimination kinetics vary largely among individual PFAS,90 (2) the
identied critical adverse eﬀects, as well as modes and mechanisms of action, may vary for individual PFAS,7 (3) mixture
toxicity may not be simply additive even if the critical adverse
eﬀects are the same88,89 and (4) although multiple PFAS are
included in these drinking water standards, many more PFAS
are neglected. Some possible solutions to the highlighted issues
are discussed in the remaining approaches reviewed, below.
Relative potency factor approach

Fig. 3 Schematic of increasing resolution in information detail of
analytical methods used for PFAS analyses.
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Existing or proposed grouping approaches based on the sum of various PFAS in drinking water

Entity

Date

Conc. (ng L1)

Sum of which PFAS?

Background

EU85

2020 (pending
nal adoption)

100; 500

100 ng L1 for sum of 20 PFAS (C4–
C13 PFSAs and C4–C13 PFCAs)

Politically agreed parameter (not based on
risk assessment) based on a precautionary
approach

500 ng L1 for ‘PFAS Total’ – the
total of all PFAS

‘PFAS Total’ suggested to be enforced
through measurement of EOF/AOF

Denmark91

2015

100

C4–C10 PFCAs, PFBS, PFHxS,
PFOS, PFOSA, and 6:2 FTS

Assumes all 12 PFAS are similarly toxic to
PFOS

Sweden87

2014

90

C4–C10 PFCAs, PFBS, PFHxS, PFOS
and 6:2 FTS

Assumes all 11 PFAS are similarly toxic to
PFOS

Australia92

2017

70

PFOS and PFHxS combined, if
both present

Assumes PFHxS is similarly toxic to PFOS

Canada93

2018

200, 600

PFOA and PFOS

When PFOS and PFOA are found together in
drinking water, a cumulative toxicity
approach is appliedb

US EPAa86

2016

70

PFOA and PFOS

Lifetime health advisory level. Assumes
additive toxicity of PFOA and PFOS

Connecticut
(USA)94

2017

70

PFHpA, PFOA, PFNA, PFHxS and
PFOS

Application of US EPA lifetime health
advisory level to the sum of ve PFAS;
assumes toxicity similar to that of PFOS and
PFOA

Maine (USA)95

2020

70

PFHxS, PFNA, PFHpA, PFOA and
PFOS

Application of US EPA lifetime health
advisory level to the sum of ve PFAS;
assumes toxicity similar to that of PFOS and
PFOA

Massachusetts
(USA)96

2018/19

20

PFHpA, PFOA, PFNA, PFDA,
PFHxS and PFOS

Proposed maximum contaminant level
(MCL) based on similarities in chemical
structure and toxicities of six PFAS to PFOS
and PFOA. Same approach as US EPA
lifetime health advisory level, but includes
an additional uncertainty factor to account
for evidence of toxicities in experimental
animals at lower levels of exposure than
those used by US EPA

Vermont (USA)97

2019

20

PFHpA, PFOA, PFNA, PFHxS and
PFOS

Interim drinking water standard based on
similar health risks of ve PFAS. Diﬀerence
to US EPA advisory is due to Vermont's
calculation being based on infant
consumption rates

a

Many US States have simply adopted US EPA's recommended Lifetime Health Advisory (LHA) of 70 ppt for PFOA and PFOS in drinking water. Several
states have passed or proposed compound-specic MCLs or health advisories, including California, Michigan, Minnesota, New Hampshire, New Jersey,
North Carolina, Ohio. Some states have recommendations for ground water that are separate from drinking water. Only sum of PFAS parameters are
included. b Cumulative toxicity estimated by adding the ratio of the monitoring result for PFOS to its maximum acceptable concentration (MAC) with
the ratio of the monitoring result for PFOA to its MAC; if the result is below or equal to one, then the water is considered safe for drinking. According
to the Canadian assessment, “science currently does not justify the use of this approach for other PFAS”.93

for a number of PFAS termed Relative Potency Factors (RPFs).98
RIVM's RPF approach builds on the assumption that the
combined toxicity of two or more substances can be calculated
based on the concept of dose addition, whereby the substances
have the same eﬀect, but diﬀer only in their toxic potencies.
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Liver toxicity data were available for a number of PFAS for rats
and mice from which RPFs could be derived. PFOA was the
reference substance and assigned an RPF of 1.0. RPFs were
estimated for 18 other PFAS with values ranging from 0.001 for
PFBS up to 10 for PFDA. Environmental concentrations can be
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converted into PFOA equivalents by multiplying the RPFs by
specic PFAS concentrations. However, questions surrounding
potential synergism of toxic eﬀects remain;99 while observations
for many endpoints have been largely additive, there is some
evidence from in vivo animal studies on specic endpoints and
in vitro studies, for some higher doses, that PFAS impacts may
be synergistic.100 Thus, a successful grouping strategy may need
to be endpoint-specic, in which the additivity of impact for the
most sensitive endpoint will need to be carefully
considered.101,102
The RPFs derived by RIVM were dened using external
exposures in rodents, i.e. based on the administered dose.
Gomis et al.90 demonstrated that the diﬀerences in RPF in rats
can be largely explained by diﬀerences in the elimination rates
of PFAS. When potencies of PFAS were compared on an
internal dose basis, the diﬀerences in potencies disappeared
and the various PFAS were equally potent. This suggests that
relative external potency is in fact largely a measure of accumulation potential, and that it may be possible to set a single
internal dose for a particular endpoint and sum across all
PFAS. Further conrmation is needed that this observation
holds across a wider variety of PFAS structures, as Gomis
et al.90 considered primarily PFAAs. Moreover, the application
of simple addition of eﬀective internal dose across many
PFAS, in the absence of eﬀects data linked to internal dose,
would require more toxicokinetic data than are currently
available. Elimination half-lives can vary by PFAS structure
(chain length and degree of branching), across species, and by
sex. Because of this, grouping for the purpose of wildlife
protection should be based on rst identifying the most
sensitive species and sex. For humans, translation of animal
data would require two key pieces of information: rst,
whether the internal dose eﬀect level is the same, and, second,
the toxicokinetic data and associated model required to
translate the eﬀective internal dose in the human back to an
external dose that can be associated with an exposure medium
(e.g. drinking water).
Finally, the RPF approach may be diﬃcult to reconcile for
substances that have the potential to biotransform; should the
parent compound, the metabolite, or both be considered in the
calculation? In each case, is there a temporal component that
needs to be taken into account, in addition to the toxicokinetic
considerations suggested above? For example, cellular assays
suggest that reactive intermediate degradation products of uorotelomer alcohols, such as short-chain saturated and unsaturated uorotelomer aldehydes, are more toxic than either the
parent compound or the terminal PFCA transformation
products.103,104
The specic RPF approach suggested by RIVM is sound if it
can be argued that liver hypertrophy is a sensitive and reliable
endpoint for all PFAAs; a problem here is that many regulatory
jurisdictions disagree with that assessment. However, a similar
additive toxicity approach could potentially be applied for those
other endpoints. The RPF approach is currently limited by the
database of toxicity data available for PFAS. Expanding this
knowledge base would require a large number of animal
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experiments and associated ethical considerations, time and
money.
Grouping only PFAAs with the same adverse eﬀect, modes and
mechanisms of action, and toxicokinetics
The most demanding grouping approach would be to only
group PFAS that have the same adverse eﬀects, modes and
mechanisms of action, and toxicokinetics for risk assessment.
The clear disadvantages with an approach of this kind are that
(1) very few substances are likely to be grouped together given
that there is currently no agreement on a single mode and
mechanism of action for even the well-studied PFCAs and
PFSAs,7 (2) modes and mechanisms of action may be tissue or
system-specic, requiring a determination of the most sensitive
or reliable eﬀect for grouping, (3) detailed eﬀect and kinetic
data are needed for each PFAS, such that individual chemicals
would still need extensive toxicological proles and (4) many
groups will be required. Such a grouping approach can be
considered only a marginal improvement on conducting risk
assessments on a chemical-by-chemical basis.

Remaining challenges and the way
forward
There are a number of challenges if the PFAS grouping
approaches summarized in this article are to be integrated into
chemical regulation and company policies, namely; (1) the
universe of PFAS2 has not been fully mapped and divided into
subcategories, (2) only for a few PFAS (e.g. certain PFAAs and
their precursors) is there suﬃcient information available to
conduct detailed hazard and risk assessments, whereas little or
no information exists on production volumes, properties and
toxic eﬀects for the vast majority of PFAS,3,8 and (3) no single
grouping strategy may be adequate for all decision contexts.
Each of these challenges will be discussed in turn below.
Within the universe of PFAS, most research to date has
focused on the occurrence and eﬀects of certain PFAAs and their
precursors due to the availability of analytical methods and
standards for these substances. Expanding beyond this domain
has been challenging because the chemical composition of
most remaining commercial products is unknown. These
factors are slowly becoming less of a barrier for identifying
overlooked and unknown PFAS due to the recent advancement
of non- and suspect-targeted screening techniques.14,57,81
However, these screening analytical methods are extremely
challenging to apply, even by experts, and the lack of methods
and analytical standards for a wider range of PFAS will remain
a barrier for regulatory purposes.
Depending on the grouping strategies to be taken by individual regulatory agencies and companies, there will inevitably
be eﬀorts in the coming years to generate the missing data for
some of the thousands of PFAS. To address these data issues,
the US EPA in partnership with the US National Toxicology
Program (NTP) has recently selected 150 PFAS (expanded from
75 10,86,105) for high-throughput toxicity testing (e.g. in vitro
assays) for multiple endpoints.106 Selection criteria for this
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subset of 150 PFAS included maximizing information to
support read-across within structure-based groupings and
capturing the structural diversity of the PFAS landscape. The
new toxicity and toxicokinetic data generated from this initiative will support the development of quantitative structure–
activity relationships (QSARs) that could facilitate lling data
gaps, as well as further grouping and prioritization of the
universe of PFAS. There are clearly relationships between PFAS
structural elements and properties and behaviour (e.g. number
of uorinated carbons in the peruoroalkyl(ether) chain,
protein binding aﬃnities, bioaccumulation potential, elimination rates, bioactivities within the PFAA/peruoroalkylether
acid subclasses),11,44,90,107 but on the other hand, critical toxic
endpoints, as well as modes and mechanisms of action vary
within the PFAS and such inconsistencies could limit the
applicability of QSARs and thus reliability of computational
tools.
Within the EU, there is already discussion to phase out all
non-essential uses of PFAS based on concerns of the chemical
class as a whole.19 Within the US, as discussed above, the focus
of the US EPA is on developing high-throughput testing
methods for PFAS,106 but otherwise adhering to the traditional
risk assessment paradigm. These diﬀerences in approaches are
inevitable given the diﬀerences in chemical management
philosophies around the world and motivations to group PFAS.
It is expected that many of the approaches reviewed in this
paper will be taken in parallel by regulatory agencies in the
diﬀerent countries. In addition, some of the reviewed grouping
approaches could even be combined (e.g. the newly identied
bioaccumulative PFAS could be regulated together with potential precursors).
An advantage of the precautionary grouping approaches
based on intrinsic properties is that relatively few data are
needed to group PFAS and regulate them. Conversely, traditional testing and regulation of PFAS on a chemical-by-chemical
basis would require huge resources and the information
required to perform risk assessments would take many years or
decades to generate. Arguably, regulation could never catch up
given that new PFAS continue to be invented and produced.
Regulation is not the only way to reduce the use of harmful PFAS
in society. Since PFAS have come under pressure in society,
there has been much innovation to produce a new generation of
alternative chemical products that aim to provide healthier,
safer, and more sustainable solutions.18,108 It should be possible
for manufacturers to make chemical products that provide the
function required in modern society while limiting or eliminating hazardous impacts over a chemical product's life-cycle.
Some product manufacturers and retailers continue to take
proactive voluntary measures to phase out PFAS from their
supply chains especially where they are non-essential or where
functional non-uorinated alternatives are available. Examples
of retailers who have phased out PFAS from their supply chains
include IKEA,109 Lindex,110 and H&M111 in Sweden, Coop112 in
Denmark, and Vaude113 and Jack Wolfskin114 in Germany. In
some jurisdictions and even internationally, PFAS are also
being phased out from certain use categories, for example, PFAS
will be phased out of use in ski waxes in international
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competitions from the winter season of 2020–2021,115 multiple
global manufacturers moved to phase out PFAS from cosmetics
by 2020,116 Denmark will ban PFAS in food contact materials in
2020,117 South Australia will transition away from the use of
PFAS in re-ghting foams by 2020118 and California designated
all PFAS used in carpets and rugs as “Chemicals of Concern”.119
However, given the complexity of supply chains and ignorance
of the full range of PFAS in society, these phase-outs may in
some use cases only be partially successful, and largely focus on
a few well known PFAS.
Given that PFAS will continue to be used in society until
alternatives are developed, scientists should work to identify the
groups and applications of PFAS among those still in use that
have unfavorable properties which make them particular
threats to human and environmental health. However, there is
a justiable concern that approaches requiring multiple
grouping approaches would result in a similarly large usage of
resources as a chemical-by-chemical regulatory approach.
Investing additional public funds for scientists to identify all
troublesome PFAS, their environmental behaviour and eﬀects
could delay broader regulatory action on PFAS. A precautionary
approach with the aim of phasing out the “non-essential” uses
of PFAS18 would reduce future exposures and the high costs of
research, regulation and cleanup of contaminated sites, while
having minimal impacts on daily life and the economy.
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